Axol Bioscience

Roslin, United Kingdom · Founded 2013 · Privately Held (backing)

Operator of a biotechnology company intended for medical research, disease modeling, and drug development. Axol Bioscience is based in Roslin, United Kingdom and was founded in 2013. Its last reported valuation was $128 million in Aug 2017. It has raised $19.9 million.

Last reported valuation
$128.1M
Oct 2026
Priced at
—
Total raised
$19.9M
Last round
—

Who backs Axol Bioscience?

14 investors
InvestorType
Scottish EnterpriseGrowth equity
SyndicateRoomVenture capital
Cambridge AngelsAngel
Amadeus Capital PartnersVenture capital
Meltwind Advisory—
Jonathan Milner—
BroadOak Capital Partners—
Calculus Capital—
Cleevely & Partners—
Darrin Disley—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Axol Bioscience investors

14 investors are on record for Axol Bioscience, including Scottish Enterprise, SyndicateRoom, Cambridge Angels and Amadeus Capital Partners.

Free account
More of Axol Bioscience with a free account
  • ·The complete investor list: 14 names
  • ·Watch Axol Bioscience: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like Axol Bioscience. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View